skip to Main Content


Synergy of two innovative solutions

Breast Cancer DNA Test powered by blockchain ecosystem


ARNA token is listed at YOBIT where you can easily buy it!

ARNA Breast Cancer DNA Test is already available for tokens!

for details please refer to

Leave your email and we will keep you up-to-date with all the news of the project!

Leave your email and we will keep you up-to-date with all the news of the project!

ARNA Breast Cancer test is already available in Moscow at our first center!

10 ARNA Tokens to get ahead of millions – sign up for testing at

Enter the Precision Medicine Market
with ARNA Genomics

Innovative Precision Medicine and Blockchain technology company specializing in the development of blood tests for early diagnosis of cancer and monitoring the efficacy of cancer treatment


ARNA Breast Cancer Test – first in the world early stage breast cancer test with UNPRECEDENTED accuracy!

Who is ARNA

ARNA Advisor Dmitry Kulish tells about ARNA project and blockchain. Full Interview

ARNA Genomics Intro

Introducing ARNA Panacea

ARNA Panacea is a Biotech Decentralized Solution, Powered by Blockchain & ARNA Tokens

ARNA Panacea by design is a platform which allows not only processing of clinical trials data but also support for researchers during R&D phase and marketplace for all types of market participants involved in clinical trials as well as direct sales of final biotech products to customers (patients).

May 2018
True: 97 False: 4

ARNA Panacea use cases

Proof Of Research

Proof of research

The Data stored in the public blockchain ARNA Panacea will be the basis of the evidence base.

Protected Research

Protected research

The ability to “scientific research” in a secure format using encrypted key in blockchain ecosystem

Big Data

Big Data

Global access to the accumulated array of information through an open API interface with the functionality required to analyze the available data.



A single blockchain platform for collecting, storing and analyzing information methods of diagnosis and treatment of cancer

Smart Blockchain

Smart Blockchain

The possibility of connecting an AI to search for “patterns” for developing new methods of cancer treatment

ARNA Tokens

ARNA Tokens

Usage through interaction within the ecosystem of patients, researchers, Regulator, CRO, pharmaceutical companies, clinics

Our Market is Huge

Women annually globally
Thousands of biotech Researchers
ARNA BC Tests only in US & Russia
M&A deals on medical market during each of the last 3 years

ARNA Panacea Blockchain Ecosystem

community roles

  • 01 Registrators
  • 02 Researchers
  • 03 Insurance companies
  • 04 Pharmaceutical companies
  • 05 Contract research organizations (CRO)
  • 06 Sponsors / Investors
  • 07 National Ethical Committees
  • 08 MDs
  • 09 Clinics
  • 10 Experts
  • 11 Regulators
  • 12 Big Data
  • 13 Patients
  • 14 Statistics

Our Vision

To revolutionize the way disruptive biotech technologies aimed to fight cancer are launched to the mass-market with the use of Blockchain technologies


Egor Melnikov

Egor Melnikov

Founder, CEO

More than 10 years ago started the project with mission to save lives from cancer. Economist and manager by education, entrepreneur by experience and spirit. Made several successful startups as founder and co-founder in advertising and production business, international logistics, IT solutions for large-scale projects, was CEO of international telecom operator. ARNA – is the meaning of Egor’s life.

George Nikitin

George Nikitin

Co-founder and COO, blockchain platform ideologist

Master of physics (diploma with honors), have 14 articles and inventions. Successfully worked in large international companies (Delloite, etc.), as well as in private equity companies. He has extensive experience as executive manager in various major private and public companies in IT, telecom, oil&gas.

Anatoliy Melnikov

Anatoliy Melnikov

Co-founder and HEAD of R&D, creator of ARNA tests

Having more than 40 years of experience in molecular biology and genetics, he is the author and co-author of more than 50 scientific articles and number of patents. For 15 years he worked in the USA in oncological centers, before that – in Canada, Hungary in various scientific companies, and Russia – a branch of the Institute of Bioorganic Chemistry of the Russian Academy of Sciences and the Institute of Biochemistry and Physiology of Microorganisms of the Russian Academy of Sciences. He graduated from the biological faculty of the Lomonosov Moscow State University.

Ilya Senechkin

Ilya Senechkin

PhD in Life Sciences, Embryology Director ("Center IVF" network of clinics, Russia)

Development Manager for Scientific and Educational Programs (F. Paulsen Assisted Reproductive Technologies Center, Russian Ministry of Health). Former: medical advisor (MC Femina, Vitrolife), clinical embryologist (MD Medical Group), Jr. scientist (Wageningen University, The Netherlands)

Magomed Chatuev

Magomed Chatuev

Software architect and developer

CTO. Has a big experience working with start-ups in the areas of e-commerce, PR & Marketing, finance, transportation, ERP development. Mainly focused on building SaaS, APIs & complex business processes automation. Had been working in international companies in Russia, Ireland, and Germany.

Alexander Mazaletskiy

Alexander Mazaletskiy

Software Architect

Founder, CEO and Principal engineer in blockchain integrator Dicoiner ( Founder and CEO in mobile development studio Zero Cool Team. 10 years experience in enterprise fintech software design and development. Last two yeast making research and implementation of blockchain systems. Graduate of IIDF-2015(Internet Initiatives Development Fund) in the team of Teslawatch startup.
15 scientific publications in the field of natural language processing

Sergey Dolgachev

Sergey Dolgachev

Co-founder, head of finance and risks management

Entrepreneur and co-owner of several companies in the oilfield service, medicine and biotech. He graduated from the Faculty of Computational Mathematics and Cybernetics of the Moscow State University Lomonosov, EMBA Higher School of Economics, studied at the Skolkovo Management School, INSEAD and graduate school of MGIMO. He has extensive executive experience in oil&gas public and private companies.

Vladimir Savanovich

Vladimir Savanovich

Co-founder, Head of Investor Relations

has a master’s degree in physics. During his professional experience, he worked in various business areas, mainly focusing on the active development of the contractual base of enterprises. He has experience in working in a Western consulting company, a resort development company, a Swiss investment fund and a Russian exploration company.

ARNA at conferences



International blockchain forum


Monaco MGF Holiday Blockchain Edition CryptoBazar Exclusive


New York
Blockchain economic forum 2017


Hong Kong
The 30th Annual AVCJ Private Equity & Venture Forum


Los Angeles
World funding summit & capital expo


Santa Clara
Blockchain in the healthcare system


One Pager

ARNA market overview



Market Overview

Market Overview


2013 2019


ARNA Genomics was established
Obtained status of a member of the Skolkovo biomedical cluster


Seed round;
Development of ARNA-Thermometr, a test for the presence of oncological diseases;
“Know-how” objects formalization


Development of ARNA Breast Cancer — a high-precision test for early detection of breast cancer


Development of ARNA Colon Cancer;
ARNA BC development is completed;
Beginning of laboratory tests of ARNA BC;
Submission of patent application No 1


End of laboratory tests of ARNA BC;
Start of ARNA BC clinical research jointly with Sechenov University;
Submission of application of Patent Cooperation Treaty No 1;
Token Distribution Event


Opening of the office and the 1st laboratory unit in the USA. Submission of application of Patent Cooperation Treaty No 2 and 3. Agreement of the regulatory strategy for ARNA BC. Launch of clinical research No 1 in the USA with FDA. ARNA CC development is completed, starting laboratory research. ARNA Panacea – launch of the beta version of blockchain-ecosystem, basic documentation for develop


Using of ARNA Panacea’s blockchain ecosystem by interested market players (regulators, investors, users, etc.) Start of development: ARNA Lung, ARNA Liver, ARNA Pancreas; ARNA BC’s entry into the US market; Clinical trials in China; National phases: USA, China, India, EU, UK, Israel, Brazil; Seed round B; Receiving the first revenue.